Moody’s affirms Excela Health’s ‘A3’ rating

Moody’s Investors Service affirmed the underlying “A3” rating on Greensburg, Pa.-based Excela Health’s $75.9 million of outstanding revenue bonds.

Advertisement

The rating affirmation is based on a number of factors, including Excela’s leading market position, strong liquidity position and solid debt service coverage.

The outlook is stable, reflecting the financial improvement it achieved through the first quarter of 2017.

More articles on healthcare finance:
6 hospital CFOs in the headlines
Pasadena to institute paramedic billing fee: 3 things to know
Georgia hospital tries to change financial course after losing $10M in last 2 years

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.